ask="N/A"
ask_size="N/A"
average_daily_volume="49973"
bid="1.79"
bid_size="300"
book_value="0.30"
change="+0.15"
change_from_200_day_moving_average="-1.33"
change_from_50_day_moving_average="-0.37"
change_from_52_week_high="-6.82"
change_From_52_week_low="0.21"
change_in_percent="+7.39%"
close="2.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.09"
ebitda="-16.15M"
eps_estimate_current_year="-1.73"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="5204000"
high="2.24"
high_52_weeks="9.00"
last_trade_date="3/16/2017"
last_trade_price="2.18"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.10"
low_52_weeks="1.98"
market_capitalization="18.71M"
moving_average_200_day="3.51"
moving_average_50_day="2.55"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="2.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-37.92%"
percent_change_from_50_day_moving_average="-14.41%"
percent_change_from_52_week_high="-75.78%"
percent_change_from_52_week_low="+10.38%"
previous_close="2.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.74"
price_per_sales="13.94"
revenue="1.25M"
shares_outstanding="8581000"
short_ratio="1.12"
stock_exchange="NCM"
symbol="VTGN"
volume="58687"
weeks_range_52="1.98 - 9.00"
